High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis

Published:2015-08-31 Issue:1 Volume:4 Page:
ISSN:2049-9957
Container-title:Infectious Diseases of Poverty
language:en
Short-container-title:Infect Dis Poverty

Author:

Li Ting,Ziniel Peter D.,He Pan-qing,Kommer Valerie P.,Crowther Gregory J.,He Min,Liu Qing,Van Voorhis Wesley C.,Williams David L.,Wang Ming-Wei

Funder

World Health Organization’s Special Programme for Research and Training in Tropical Diseases

Ministry of Science and Technology of the People's Republic of China

National Health and Family Planning Commission of the People's Republic of China

Shanghai Science and Technology Development Fund

Thousand Talents Program in China

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40249-015-0071-z.pdf

Reference22 articles.

1. King CH, Dangerfield-Cha M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 2008;4(1):65–79. doi: 10.1177/1742395307084407 .

2. Hotez PJ, Engels D, Fenwick A, Savioli L. Africa is desperate for praziquantel. Lancet. 2010;376(9740):496–8. doi: 10.1016/S0140-6736(10)60879-3 .

3. Hotez PJ, Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis. 2009;3(9), e485. doi: 10.1371/journal.pntd.0000485 .

4. Domling A, Khoury K. Praziquantel and schistosomiasis. ChemMedChem. 2010;5(9):1420–34. doi: 10.1002/cmdc.201000202 .

5. Cioli D, Basso A, Valle C, Pica-Mattoccia L. Decades down the line: the viability of praziquantel for future schistosomiasis treatment. Expert Rev Anti-Infect Ther. 2012;10(8):835–7. doi: 10.1586/eri.12.70 .

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The “Doorstop Pocket” In Thioredoxin Reductases─An Unexpected Druggable Regulator of the Catalytic Machinery;Journal of Medicinal Chemistry;2024-09-09

2. Fragment library screening by X-ray crystallography and binding site analysis on thioredoxin glutathione reductase of Schistosoma mansoni;Scientific Reports;2024-01-18

3. Fragment library screening by X-ray crystallography and hit optimization against thioredoxin glutathione reductase of Schistosoma mansoni;2023-08-14

4. Synthesis, virtual screening, and computational approach of 6-(4-metoxyphenyl)-4-phenyl-1,2-dihydropyrimidin-2-one as a potential target for thioredoxin glutathione reductase (TGR);Journal of Molecular Structure;2023-08

5. Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms;Molecules;2023-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3